The Lymphatic System and its Specific Growth Factor Vascular Endothelial Growth Factor C in Kidney Tissue and in Renal Cell Carcinoma - Abstract
Friday, 03 July 2009
Medical Statistics, University Hospital Mannheim, Mannheim, Germany.
read more
|
Long-term Survival in Patients Undergoing Radical Nephrectomy and Inferior Vena Cava Thrombectomy: Single-Center Experience - Abstract
Thursday, 02 July 2009
Department of Urology, Miller School of Medicine, University of Miami, Miami, FL, USA.
read more
|
Second Opinion Pathology in Tertiary Care of Patients with Urologic Malignancies - Abstract
Tuesday, 23 June 2009
Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL 62794, USA.
read more
|
De Novo Cancers Arising in Organ Transplant Recipients are Associated with Adverse Outcomes Compared with the General Population - Abstract
Monday, 22 June 2009
Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0558, USA.
read more
|
Editorial - The Necessity of Adrenalectomy at the Time of Radical Nephrectomy: A Systematic Review
Tuesday, 16 June 2009
BERKELEY, CA (UroToday.com) - To take the adrenal or not at the time of radical nephrectomy, that is the question.
Login to read more...
|
The Necessity of Adrenalectomy at the Time of Radical Nephrectomy: A Systematic Review - Abstract
Wednesday, 10 June 2009
Department of Urology, New York University School of Medicine, New York, New York 10016, USA.
read more
|
How to Optimise Treatment Compliance in Metastatic Renal Cell Carcinoma with Targeted Agents - Abstract
Tuesday, 09 June 2009
Department of Medical Oncology and Radiotherapy, Hôpital Saint-Andre, University Hospital, Bordeaux and Université Bordeaux, 2 Victor Segalen, Bordeaux, France.
read more
|
2009 Update on the Classification of Renal Epithelial Tumors in Adults - Abstract
Tuesday, 09 June 2009
Anatomical Pathology Unit, Department of Surgery, Faculty of Medicine, Reina Sofia University Hospital, Cordoba, Spain.
read more
|
A Lower Risk of Dying from Urological Cancer in Down Syndrome: Clue for Cancer Protecting Genes on Chromosome 21 - Abstract
Tuesday, 09 June 2009
Laboratoire d'Anatomie Pathologique, Centre Hospitalier, Tulle, France.
read more
|
Afinitor® Recommended for Use in the European Union for Patients with Advanced Kidney Cancer
Tuesday, 09 June 2009
BASEL, SWITZERLAND (Press Release) - May 29, 2009
read more
|
Editorial - Laparoscopic Radical Versus Partial Nephrectomy for Tumors >4cm: Intermediate-term Oncologic and Functional Outcomes
Monday, 08 June 2009
BERKELEY, CA (UroToday.com) - Nephron-sparing surgery has become the well-accepted method for treating patients with localized tumor disease of the kidney.
Login to read more...
|
A Prospective Analysis of the Association Between Macronutrient Intake and Renal Cell Carcinoma in the European Prospective Investigation into Cancer and Nutrition - Abstract
Monday, 08 June 2009
Cancer Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
read more
|
Tyrosine Kinase Inhibition in Renal Cell Carcinoma and Gastrointestinal Stromal Tumours: Case Reports - Abstract
Monday, 08 June 2009
Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Catholic University Leuven, Leuven, Belgium.
read more
|
Sorafenib Tosylate in Advanced Kidney Cancer: Past, Present and Future - Abstract
Monday, 08 June 2009
Medical Oncology Laboratory of Pre-Clinical Oncology and Developmental Therapeutics, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy.
read more
|
Beyond the Abstract - The Role of Liver Transplantation Techniques in the Surgical Management of Advanced Renal Urothelial Carcinoma With or Without Inferior Vena Cava Thrombus
Friday, 05 June 2009
BERKELEY, CA (UroToday.com) -
Advanced urothelial carcinoma of the renal pelvis
Login to read more...
|
Clinical Implications of Hypoxia Inducible Factor in Renal Cell Carcinoma - Abstract
Friday, 05 June 2009
Department of Urology, University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute, Pittsburgh, PA 15232, USA.
read more
|
Prognostic Markers and New, Innovative Treatments in Renal Cell Carcinoma - Abstract
Friday, 05 June 2009
Department of Urologic Surgery, University of Medicine and Pharmacy, Timisoara, Romania.
read more
|
Future Developments in Renal Cell Carcinoma - Abstract
Friday, 05 June 2009
Solid Tumor Oncology (Genitourinary and Gastrointestinal) Section, Medical Oncology Service, Hospital Del Mar, Barcelona, Spain.
read more
|
Beyond the Abstract - Complications of Image-Guided Radiofrequency Ablation of Renal Cell Carcinoma: Causes, Imaging Features and Prevention Methods
Thursday, 04 June 2009
BERKELEY, CA (UroToday.com) - Radiofrequency (RF) ablation of renal cell carcinoma (RCC) has been accepted as a minimally invasive treatment for patients who are not able to undergo surgery.
Login to read more...
|
Diagnostic and Prognostic Impact of p63 Immunoreactivity in Renal Malignancies - Abstract
Thursday, 04 June 2009
Department of Pathology, Dokuz Eylul University Medical Faculty, Inciralti, Izmir, Turkey.
read more
|
NOTES Hybrid Transvaginal Radical Nephrectomy for Tumor: Stepwise Progression Toward a First Successful Clinical Case - Abstract
Thursday, 04 June 2009
Centro de Robótica y De Invasión Mínima Unidad de Urología, Instituto Médico La Floresta, Caracas, Venezuela.
read more
|
Systematic Review of Pancreatic Surgery for Metastatic Renal Cell Carcinoma - Abstract
Thursday, 04 June 2009
Department of Surgery, Academic Medical Centre at the University of Amsterdam, Amsterdam, The Netherlands.
read more
|
ASCO 2009 - Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The object of this study was to identify genetic markers in the pharmacokinetic and pharmacodynamic pathway of sunitinib that predispose patients to the development of toxicities.
Login to read more...
|
ASCO 2009 - VEGF Single Nucleotide Polymorphisms and Correlation to Sunitinib-Induced Hypertension in Metastatic Renal Cell Carcinoma Patients - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The authors investigated the association among VEGF single nucleotide polymorphisms (SNPs) and the development of hypertension in metastatic RCC patients undergoing sunitinib treatment.
Login to read more...
|
ASCO 2009 - Phase II Presurgical Study of Bevacizumab Plus Erlotinib in Untreated Patients with Metastatic Renal Cell Carcinoma - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The objective of this study was to further define the safety and efficacy of bevacizumab therapy in patients with metastatic renal cell carcinoma (mRCC), prior to surgery.
Login to read more...
|
ASCO 2009 - Use of CA9 Gene Single Nucleotide Polymorphisms to Predict Prognosis and Treatment Response of Metastatic Renal Cell Carcinoma - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - This study investigated the role of single nucleotide polymorphisms (SNPs) and mutations of the CA9 gene with CAIX expression response to immunotherapy and survival.
Login to read more...
|
ASCO 2009 - Final Results of the Phase III, Randomized, Double-Blind AVOREN Trial of First-Line Bevacizumab + Interferon-α2a in Metastatic Renal Cell Carcinoma - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The authors reported the final results from the bevacizumab plus interferon vs. interferon alone trial for patients with metastatic renal cell carcinoma (mRCC).
Login to read more...
|
ASCO 2009 - A Multicenter Phase II Study of Cisplatin, Gemcitabine, and Bevacizumab as First-Line Chemotherapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU-0475 - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - This study investigated the addition of bevacizumab to the standard regimen of cisplatin/gemcitabine as first-line therapy for patients with metastatic urothelial carcinoma (UC).
Login to read more...
|
ASCO 2009 - A Randomized, Double-Blind Phase III Study of Pazopanib in Treatment-Naive and Cytokine-Pretreated Patients with Advanced Renal Cell Carcinoma - Session Presentation
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - Study results indicate a favorable risk/benefit profile in treatment of patients with treatment-naive and cytokine-pretreated advanced RCC.
Login to read more...
|
ASCO 2009 - A Randomized, Double-Blind Phase III Study of Pazopanib in Treatment-Naive and Cytokine-Pretreated Patients with Advanced Renal Cell Carcinoma - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - In this study, the safety and efficacy of the oral multikinase angiogenesis inhibitor pazopanib was compared to placebo in patients with advance RCC.
Login to read more...
|
ASCO 2009 - Independent Validation of the 2002 UICC TNM Staging System for Papillary Renal Cell Carcinoma in a Multicenter Cohort - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - The accuracy of the standard UICC TNM classification for predicting outcomes for patients with papillary renal cell carcinoma (pRCC) is unknown.
Login to read more...
|
ASCO 2009 - Failure of Initial VEGF-Targeted Therapy in Metastatic Renal Cell Carcinoma: What Next? - Session Highlights
Wednesday, 03 June 2009
ORLANDO, FL, USA (UroToday.com) - In this study, patient characteristics data on second-line therapies and outcomes were analyzed for patients with metastatic renal cell carcinoma (RCC) who received anti-VEGF therapy at seven centers.
Login to read more...
|
Renal Papillary Carcinoma Classification into Subtypes may be Reproduced by Nuclear Morphometry - Abstract
Wednesday, 03 June 2009
Department of Pathomorphology, Collegium Medicum, Jagiellonian University, Kraków, Poland.
read more
|
New Therapeutic Opportunities in Metastatic Renal Cell Carcinoma - Abstract
Wednesday, 03 June 2009
Medizinische Klinik, St. Claraspital, Basel.
read more
|
Radiofrequency Ablation of Small Renal Cortical Tumours in Healthy Adults: Renal Function Preservation and Intermediate Oncological Outcome - Abstract
Wednesday, 03 June 2009
Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
read more
|
ASCO 2009 - Efficacy and Toxicity of Sunitinib in Patients with Metastatic Renal Cell Carcinoma with Severe Renal Impairment or on Haemodialysis - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - The authors investigated the efficacy and toxicity of sunitinib in patients with metastatic RCC and severe renal insufficiency.
Login to read more...
|
ASCO 2009 - Sunitinib in Patients with Unresectable Primary Renal Cell Carcinoma - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - In this study, the ability of sunitinib to shrink unresectable metastatic RCC was evaluated.
Login to read more...
|
ASCO 2009 - Association of Percentage of Tumor Burden Removed with Debulking Nephrectomy and Progression-Free Survival in Metastatic Renal Cell Carcinoma Patients Treated with VEGF-Targeted Therapy - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Cytoreductive nephrectomy is the standard of care for good performance patients with metastatic RCC.
Login to read more...
|
ASCO 2009 - Laparoscopic Renal Cryoablation: Risk Factor Analysis to Predict Oncologic Outcomes with Minimum 5-Year Follow-Up - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Ablation therapy is becoming an increasingly popular alternative for patients with renal masses.
Login to read more...
|
ASCO 2009 - Macroscopic Versus Microscopic Vascular Tumour Invasion in Patients with Clear Cell Renal Cell Carcinoma: Does it Make a Difference? - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - This study evaluated the prognostic impact of macroscopic vs. microscopic vascular invasion on metastasis-free survival in patients with clear cell RCC.
Login to read more...
|
ASCO 2009 - A Nomogram Predicting Disease-Specific Survival after Nephrectomy for Papillary Renal Cell Carcinoma - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Most prognostic studies in RCC focus on patients with clear cell histology.
Login to read more...
|
ASCO 2009 - Histopathology in Surgically Treated Renal Cell Carcinoma: Is There a Survival Difference when Stratified by Stage? - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - The object of this study was to determine the role of RCC histopathology on stage-specific survival rate in a population-based cohort.
Login to read more...
|
ASCO 2009 - Prognostic Risk Group Classification for Patients with Platinum-Refractory Metastatic Urothelial Cancer Treated with Second-Line Chemotherapy - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Second-line chemotherapy agents for patients with platinum-refractory metastatic urothelial cancer (UC) are associated with low response rated and short progression-free and overall survival rates.
Login to read more...
|
ASCO 2009 - Adjuvant Chemotherapy for High-Risk Upper Tract Urothelial Carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Little evidence exists regarding the use of adjuvant chemotherapy following radical nephroureterectomy for the management of patients with upper tract urothelial carcinoma (UTUC).
Login to read more...
|
ASCO 2009 - Vascular Thromboembolic Events in Patients with Advanced Urothelial Cancer Treated with Carboplatin/Gemcitabine Alone or in Combination with Bevacizumab - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Cisplatin-based chemotherapy is the first-line agent for metastatic urothelial carcinoma (UC).
Login to read more...
|
ASCO 2009 - A Phase II Study of Sunitinib on a Continuous Dosing Schedule in Patients with Relapsed or Refractory Urothelial Carcinoma - Session Highlights
Tuesday, 02 June 2009
ORLANDO, FL, USA (UroToday.com) - Sunitinib has demonstrated activity as a second-line agent for patients with advanced urothelial carcinoma (UC) when administered on a 4 week on, 2 week off schedule.
Login to read more...
|
Feasibility of Sequential Use of Sunitinib and Temsirolimus in Advanced Renal Cell Carcinoma - Abstract
Tuesday, 02 June 2009
Department of Urology, Lukas Hospital, Neuss, Germany.
read more
|
Nephron-Sparing Surgery for the Treatment of Small Renal Tumors. The Role of Radiofrequency - Abstract
Tuesday, 02 June 2009
Unidad de Enndourología y laparoscopía Urológica, Clínica Santa María, Santiago, Chile.
read more
|
Purse-string Technique for Laparoscopic Excision of a Bladder Mucosal Cuff in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract: Initial Report with Intermediate Follow-Up - Abstract
Tuesday, 02 June 2009
Urology and Nephrology centre, Mansoura University, Mansoura, Egypt.
read more
|
BJUI Mini Reviews - Neuroendocrine Tumours of the Urinary System and Male Genital Organs: Clinical Significance
Monday, 01 June 2009
The aim of this review is to discuss the clinical features, origins, morphological and immunophenotypic profiles, and prognosis of neuroendocrine tumours of the urinary system and male genital organs.
Login to read more...
|
Renal Cancer 
